? blocker therapy plays a major role in the treatment of cardiovascular diseases. For many years ? blockers were used for their antiischaemic, antiarryhthmic and antihypertensive properties. However, ? blocking agents are generally considered as first choice therapy in simptomatic patients with mitral valve prolapse.

Terapia cu ? blocante joaca un rol major în tratamentul maladiilor cardiovasculare. Pe parcursul anilor ? blocantele au fost utilizate pentru proprietatile lor antiischemice, antiaritmice si antihipertensive. Agentii ? blocanti sunt considerati la pacientii simptomatici cu prolaps de valva mitrala, terapia de prima alegere.